We are live on ! Find out more
CCMU

Cheyne Capital Management (UK) Portfolio holdings

AUM $27.9M
1-Year Est. Return 36.14%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+36.14%
3 Year Est. Return
+35.61%
5 Year Est. Return
+211.68%
10 Year Est. Return
+661.99%
AUM
$57.2M
AUM Growth
+$10.5M
Cap. Flow
+$11.3M
Cap. Flow %
19.68%
Top 10 Hldgs %
46.43%
Holding
72
New
39
Increased
1
Reduced
6
Closed
13

Top Buys

Rank Stock Value
1
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$1.61M
2
XENE icon
Xenon Pharmaceuticals
XENE
+$1.55M
3
RAPT
RAPT Therapeutics
RAPT
+$1.44M
4
PLRX icon
Pliant Therapeutics
PLRX
+$1.38M
5
ALPN
Alpine Immune Sciences Inc
ALPN
+$1.16M

Top Sells

Rank Stock Value
1
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$4.41M
2
CRWD icon
CrowdStrike
CRWD
+$2.04M
3
ATVI
Activision Blizzard
ATVI
+$963K
4
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
+$844K
5
RDNT icon
RadNet
RDNT
+$601K

Sector Composition

Rank Sector Weight
1 Healthcare 41.62%
2 Energy 19.93%
3 Technology 17.56%
4 Materials 10.23%
5 Consumer Discretionary 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRMR icon
51
Larimar Therapeutics
LRMR
$432M
$263K 0.46%
+63,680
New +$217K
BRY
52
DELISTED
Berry Corp
BRY
$248K 0.43%
31,000
– –
BIRD icon
53
Smartbird Inc
BIRD
$22.3M
$242K 0.42%
+5,000
New +$293K
DTIL icon
54
Precision BioSciences
DTIL
$207M
$226K 0.4%
+6,336
New +$250K
GRCL
55
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$226K 0.39%
+98,120
New +$301K
RRC icon
56
Range Resources
RRC
$8.95B
$225K 0.39%
+9,000
New +$246K
SWN
57
DELISTED
Southwestern Energy Company
SWN
$216K 0.38%
+37,000
New +$243K
GBIO
58
DELISTED
Generation Bio
GBIO
$201K 0.35%
+5,113
New +$268K
DNTH icon
59
Dianthus Therapeutics
DNTH
$6.09B
$18.6K 0.03%
2,948
– –
AAPL icon
60
Apple
AAPL
$4.57T
– –
-275
Closed -$212K
CRWD icon
61
CrowdStrike
CRWD
$218B
– –
-49,600
Closed -$2.04M
FCX icon
62
Freeport-McMoran
FCX
$97.5B
– –
-16,500
Closed -$451K
LCA
63
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
– –
-33,417
Closed -$328K
KVSA
64
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
– –
-11,723
Closed -$115K
MBAC
65
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
– –
-39,304
Closed -$386K
MBSC
66
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
– –
-13,043
Closed -$132K
MIT
67
DELISTED
Mason Industrial Technology, Inc.
MIT
– –
-37,844
Closed -$371K
GTPB
68
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
– –
-39,957
Closed -$392K
BSKY
69
DELISTED
Big Sky Growth Partners, Inc. Class A Common Stock
BSKY
– –
-13,815
Closed -$135K
DHBC
70
DELISTED
DHB Capital Corp. Class A common stock
DHBC
– –
-37,693
Closed -$371K
SWCH
71
DELISTED
Switch, Inc. Class A Common Stock
SWCH
– –
-131,000
Closed -$4.41M
FRW
72
DELISTED
PWP Forward Acquisition Corp. I Class A Common Stock
FRW
– –
-44,339
Closed -$436K
1 2
3

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return
TCM
TORQ Capital Management Hong Kong $38.1M AUM 2.81% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
AMC
AKKR Management Company Menlo Park, California $42.5M AUM 123.1% 1-Year Est. Return
P
Pariax Newport Beach, California $44.3M AUM 12.57% 1-Year Est. Return
AOGP
Addition One General Partner New York $45.7M AUM
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return

Cheyne Capital Management (UK)'s Q4 2022 Portfolio in Review

As of Q4 2022, Cheyne Capital Management (UK) held 72 positions worth $57.2M, up 22% from $46.8M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cheyne Capital Management (UK) deployed $11.3M of net new capital in Q4 2022, opening 39 new positions and adding to 1 existing holding. Its largest new stake was CinCor Pharma, Inc. Common Stock: 67,557 shares worth $830K.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 6.4% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Activision Blizzard, an estimated $963K trimmed.

  • Cheyne Capital Management (UK)'s largest Q4 2022 buy was CinCor Pharma, Inc. Common Stock: 67,557 shares worth $830K.
  • Cheyne Capital Management (UK) added most to Expand Energy Corp in Q4 2022, an estimated $84.8K increase.
  • Cheyne Capital Management (UK)'s biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $963K.
  • Cheyne Capital Management (UK) fully exited Switch, Inc. Class A Common Stock in Q4 2022, selling an estimated $4.41M.
  • Cheyne Capital Management (UK)'s ten largest holdings make up 46% of its $57.2M portfolio in Q4 2022.
  • Cheyne Capital Management (UK) opened 39 new positions and closed 13 in Q4 2022.
  • Cheyne Capital Management (UK)'s portfolio value rose 22% quarter-over-quarter to $57.2M.

Based on Cheyne Capital Management (UK)'s 13F filing for Q4 2022, filed 10 Feb 2023.